NEWS IN BRIEF

BioStem Technologies expands API site in Florida, US

By Flora Southey

- Last updated on GMT

GettyImages/eternalcreative
GettyImages/eternalcreative

Related tags Pharmacology Pharmaceutical drug

Quality Pharma Ingredients – a subsidiary of BioStem Technologies – is expanding its API facility in Oakland Park, Florida, US.

The expansion will add environmentally controlled warehouse space for storage of the company’s active pharmaceutical ingredients (APIs), and a pack-out area for order fulfillment. 

The company has also added a storage cage to handle US Drug Enforcement Administration (DEA) controlled substances with low to moderate potential for abuse.

BioStem Technologies COO Andrew Van Vurst told us it is in the process of applying to the Administration for Schedule III-V holding status, which will enable Quality Pharma Ingredients (QPI) to add DEA regulated products to its portfolio.

Van Vurst said he expects the expansion to be completed by the first quarter of 2018, and will create between five and eight new jobs across the quality, processing and warehouse sectors.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars